Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sprague

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Medicinal Chemistry|May 18, 2016
Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology InsightB Barry Touré, John Giraldes, Troy Smith, et al.
Journal of Medicinal Chemistry|May 27, 2017
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxCGrazia Piizzi, David T Parker, Yunshan Peng, et al.
Cancer Research|August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulinAndrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.
Emerging Infectious Diseases|May 27, 2017
High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika VirusAndrew D Haddow, Aysegul Nalca, Franco D Rossi, et al.
Science (New York, N.Y.)|February 26, 2016
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreakZachary A Bornholdt, Hannah L Turner, Charles D Murin, et al.
The American Journal of Tropical Medicine and Hygiene|December 28, 2017
African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In VivoDarci R Smith, Thomas R Sprague, Bradley S Hollidge, et al.
Science (New York, N.Y.)|February 26, 2016
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5Konstantinos J Mavrakis, E Robert McDonald, Michael R Schlabach, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Medicinal Chemistry|May 18, 2016
Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology InsightB Barry Touré, John Giraldes, Troy Smith, et al.
Journal of Medicinal Chemistry|May 27, 2017
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxCGrazia Piizzi, David T Parker, Yunshan Peng, et al.
Cancer Research|August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulinAndrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.
Emerging Infectious Diseases|May 27, 2017
High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika VirusAndrew D Haddow, Aysegul Nalca, Franco D Rossi, et al.
Science (New York, N.Y.)|February 26, 2016
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreakZachary A Bornholdt, Hannah L Turner, Charles D Murin, et al.
The American Journal of Tropical Medicine and Hygiene|December 28, 2017
African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In VivoDarci R Smith, Thomas R Sprague, Bradley S Hollidge, et al.
Science (New York, N.Y.)|February 26, 2016
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5Konstantinos J Mavrakis, E Robert McDonald, Michael R Schlabach, et al.
Pageof 5